These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7380587)

  • 1. Time-blind analysis and other video-strategies in phase II trials of psychotropic drugs.
    Müller-Oerlinghausen B; Renfordt E
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):99-103. PubMed ID: 7380587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-blind evaluation of psychopathology in drug research.
    Bobon DP
    Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [General methodological problems of psychotropic drug trials (author's transl)].
    Heimann H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):119-29. PubMed ID: 360236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].
    Woggon B
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):140-6. PubMed ID: 360238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B; Angst J
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The AMDP scales in a phase II evaluation of psychotropic drugs].
    Digonnet C; Boyer P; Puech AJ; von Frenckell R; Weil JS
    Acta Psychiatr Belg; 1987; 87(2):245-52. PubMed ID: 3618275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodological problems in studying psychotropic drugs with special reference of the AMP system].
    Baumann U; Rothweiler R; Scheidegger P
    Arzneimittelforschung; 1975 Feb; 25(2):270-3. PubMed ID: 1173047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Planning of psychotropic drug trials. Control of interfering factors].
    Schmocker AM
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):149-51. PubMed ID: 360239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract]   [Full Text] [Related]  

  • 18. [The method of joined multi-center studies in clinical psychopharmacology].
    Fleischhauer J
    Schweiz Arch Neurol Neurochir Psychiatr; 1975; 117(2):269-81. PubMed ID: 1224189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of the clinical evaluation of psychotropic drugs].
    Moizeszowicz J
    Acta Psiquiatr Psicol Am Lat; 1975 Mar; 21(1):41-51. PubMed ID: 1163268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.